Internet surveillance: Content analysis and monitoring of product-specific internet prescription opioid abuse-related postings

Clinical Journal of Pain

Volumn 23, Issue 7, 2007, Pages 619-628

  Butler, Stephen F ^a   Venuti, Synne Wing ^a   Benoit, Christine ^a   Beaulaurier, Richard L ^d   Houle, Brian ^a   Katz, Nathaniel ^a,b,c  

^a INFLEXXION INC   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Analgesic Research   (United States)

^d FLORIDA INTERNATIONAL UNIVERSITY   (United States)

Author keywords

Aberrant drug behaviors; Content analysis; Internet monitoring; Opioids; Prescription drug abuse

Indexed keywords

HYDROCODONE BITARTRATE PLUS PARACETAMOL; MORPHINE SULFATE; OXYCODONE;

ARTICLE; CODING; CONTENT ANALYSIS; DATA ANALYSIS; DRUG MONITORING; HUMAN; INTERNET; INTERRATER RELIABILITY; OPIATE ADDICTION; PRESCRIPTION; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ANALGESICS, OPIOID; HUMANS; INTERNATIONALITY; INTERNET; NATURAL LANGUAGE PROCESSING; OPIOID-RELATED DISORDERS; POPULATION SURVEILLANCE; PRESCRIPTIONS, DRUG; PREVALENCE;

EID: 34548126479     PISSN: 07498047     EISSN: None     Source Type: Journal    
DOI: 10.1097/AJP.0b013e318125c5cf     Document Type: Article

References (24)

1. Arfken CL, Cicero TJ. Postmarketing surveillance for drug abuse. Drug Alcohol Depend. 2003;70:S97-S105.
2. US General Accounting Office. Prescription drugs: OxyContin abuse and diversion and efforts to address the problem. OxyContin Abuse and Diversion Report to Congressional Requesters (GAO-04-110). Available at: http://frwebgate.access.gpo.gov/cgi-bin/useftp.cgi?IPaddress=162.140.64.88&. lename=d04110.pdf&directory=/diskb/wais/data/gao. Accessed 9/1/2005.
3. Volkow ND. Message from the Director: Increased abuse of prescription drugs is cause for concern. Available at: http://www.drugabuse.gov/about/ welcome/message304.html. Accessed 9/1/2005.
4. Gfroerer J. Abuse of pain relievers: Results from the 2002 National Survey on Drug Use and Health (NSDUH, 2003). Office of Applied Studies, Substance Abuse and Mental Health Services Administration. 2003. Available at: http://www.fda.gov/OHRMS/DOCKETS/AC/03/slides/3978S1_07_Gfroerer.ppt. Accessed 11/10/2005.
5. Mounteney J, Leirvåg SE. Providing an earlier warning of emerging drug trends: the Fare Var System. Drugs Educ Prev Pol. 2004;11:449-471.
6. Zinkham GM, Kwak H, Morrison M, et al. Web-based chatting: consumer communication in cyberspace. J Consum Psychol. 2003;13:17-27.
7. Wax PM. Just a click away: recreational drug websites on the Internet. Pediatrics. 2002;109:1-4.
8. Cicero TJ, Adams EH, Geller A, et al. A postmarketing surveillance program to monitor Ultram (tramadol hydrocloride) abuse in the United States. Drug Alcohol Depend. 1999;57:7-22.
9. Zacny J, Bigelow G, Compton P, et al. College on problems of drug dependence taskforce on prescription opioid non-medical use and abuse: position statement. Drug Alcohol Depend. 2003;69:215-232.
10. Butler SF, Benoit C, Budman SH, et al. Development and validation of an Opioid Attractiveness Scale: a novel measure of the attractiveness of opioid products to potential abusers. Harm Reduct J. 2006;3:5.
11. Culnan MJ. Georgetown Internet privacy policy survey: Report to the federal trade commission: Appendix B. Methodology. 1999. Available at: http://scholar.google.com/scholar?hl=en&lr=&client=firefox-a&q= cache:yW0jZZksL0QJ:www.msb.georgetown.edu/faculty/culnanm/GIPPS/gipps1. pdf+author:%22Culnan%22+intitle:%22Georgetown+Internet+Privacy+Policy+Survey: +Report+to+the+...%22+. Accessed 11/10/2005.
12. Macgowan MJ, Beaulaurier RL. Using qualitative data analysis software in teaching about group work practice. In: Beaulaurier RL, Haffey M, eds. Technology in Social Work Education and Curriculum. New York, NY: Haworth Press, Inc; 2005:45-56.
13. Neuendorf KA. Content Analysis Guidebook. Thousand Oaks, CA: Sage Publications; 2002.
14. Patton MQ. Qualitative Research and Evaluation Methods. 3rd ed. Thousand Oaks, CA: Sage Publications; 2002.
15. ONDCP. (2004). National Synthetic Drugs Action Plan: The Federal Government response to the production, trafficking, and abuse of synthetic drugs and diverted pharmaceutical products. Available at: http://www. whitehousedrugpolicy.gov/publications/national_synth_drugs/national_synth_drugs. pdf Accessed 1/28/07.
16. Kraut R, Olson J, Banaji M, et al. Psychological research online: Report of Board of Scientific Affairs' Advisory Group on the conduct of research on the Internet. Am Psychol. 2004;59:105-117.
17. Cicchetti DV. Guidelines, criteria, and rules of thumb for evaluating normed and standardized assessment instruments in psychology. Psychol Assess. 1994;6:284-290.
18. Banerjee M, Capozzoli M, McSweeney L, et al. Beyond kappa: a review of interrater agreement measures. Can J Stat. 1999;27:3-23.
19. Cicchetti DV, Chinye L, Fontana AF, et al. A computer program for assessing specific category rater agreement for qualitative data. Educ Psychol Meas. 1978;38:805-881.
20. Cicero TJ, Dart RC, Inciardi JA, et al. The Development of a Comprehensive Risk-Management Program for Prescription Opioid Analgesics: Researched Abuse, Diversion and Addiction-Related Surveillance (RADARS®). Pain Med. 2007;8:157-170.
21. Nonnecke B, Preece J. Lurker demographics: Counting the silent. Available at: http://portal.acm.org/citation.cfm?id=332409&dl=GUIDE&coll= &CFID=15151515&CFTOKEN=6184618. Accessed 11/10/2005
22. Gladwell M. The Tipping Point. New York, NY: Abacus; 2000.
23. Walsh G, Gwinner KP, Swanson SR. What makes mavens tick? Exploring motives of market mavens' initiation of information diffusion. J Consum Market. 2004;21:109-122.
24. Robert G, Stevens A, Gabbay J. Early warning systems' for identifying new healthcare technologies. Health Technol Assess. 1999;3:1-108.